{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T06:49:27Z","timestamp":1763534967904},"reference-count":27,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2009,4,1]],"date-time":"2009-04-01T00:00:00Z","timestamp":1238544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins &amp; Other Lipid Mediators"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1016\/j.prostaglandins.2008.10.002","type":"journal-article","created":{"date-parts":[[2008,10,28]],"date-time":"2008-10-28T14:49:37Z","timestamp":1225205377000},"page":"63-67","source":"Crossref","is-referenced-by-count":16,"title":["Celecoxib exacerbates hepatic fibrosis and induces hepatocellular necrosis in rats treated with porcine serum"],"prefix":"10.1016","volume":"88","author":[{"given":"Hao","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prostaglandins.2008.10.002_bib1","first-page":"247","article-title":"Anti-inflammatory and side effects of cyclooxygenase inhibitors","volume":"59","author":"Suleyman","year":"2007","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.bbrc.2005.08.152","article-title":"Coupling between cyclooxygenases and terminal prostanoid synthases","volume":"338","author":"Ueno","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2215\/CJN.00890805","article-title":"Update on cyclooxygenase-2 inhibitors","volume":"1","author":"Harris","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/hep.21493","article-title":"Prostaglandin I(2) and E(2) mediate the protective effects of cyclooxygenase-2 in a mouse model of immune-mediated liver injury","volume":"45","author":"Yin","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.prostaglandins.2004.07.005","article-title":"PGE2 exerts its effect on the LPS-induced release of TNF-alpha, ET-1, IL-1alpha IL-6 and IL-10 via the EP2 and EP4 receptor in rat liver macrophages","volume":"74","author":"Treffkorn","year":"2004","journal-title":"Prostag Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0090-6980(99)00059-3","article-title":"One year follow-up of patients treated with misoprostol in acute phase of viral hepatitis B","volume":"60","author":"Flisiak","year":"2000","journal-title":"Prostag Other Lipid Mediat"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11916-005-0017-4","article-title":"An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors","volume":"9","author":"Williams","year":"2005","journal-title":"Curr Pain Headache Rep"},{"issue":"Suppl. 3A","key":"10.1016\/j.prostaglandins.2008.10.002_bib8","doi-asserted-by":"crossref","first-page":"13S","DOI":"10.1016\/S0002-9343(00)00728-2","article-title":"Gastrointestinal toxic side effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2-specific inhibitors","volume":"110","author":"Buttgereit","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib9","first-page":"1819","article-title":"The choice of selective COX-2 inhibitors","volume":"65","author":"Hiratsuka","year":"2007","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.freeradbiomed.2005.08.038","article-title":"Nimesulide-induced hepatic mitochondrial injury in heterozygous Sod2(+\/\u2212) mice","volume":"40","author":"Ong","year":"2006","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00428-002-0612-2","article-title":"COX-2 inhibitor (nimesulide) induced acute liver failure","volume":"440","author":"Stadlmann","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/j.1440-1827.1994.tb02944.x","article-title":"Captopril reduces collagen and mast cell and eosinophil accumulation in pig serum-induced rat liver fibrosis","volume":"44","author":"Ramos","year":"1994","journal-title":"Pathol Int"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1478-3231.2005.01202.x","article-title":"Effect of celecoxib on experimental liver fibrosis in rat","volume":"26","author":"Hui","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib14","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jep.2006.08.019","article-title":"Effects and mechanisms of total glucosides of paeony on adjuvant arthritis in rats","volume":"109","author":"Xu","year":"2007","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1023\/A:1012860509440","article-title":"Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut","volume":"25","author":"Kankuri","year":"2001","journal-title":"Inflammation"},{"issue":"5","key":"10.1016\/j.prostaglandins.2008.10.002_bib16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00280-007-0668-4","article-title":"Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer","volume":"62","author":"Heer","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.yexmp.2005.08.007","article-title":"Serological and immunohistochemical studies on porcine-serum-induced hepatic fibrosis in rats","volume":"79","author":"Baba","year":"2005","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib18","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1055\/s-2008-1040457","article-title":"Experimental models of hepatic fibrosis: a review","volume":"10","author":"Tsukamoto","year":"1990","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib19","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/hep.1840180626","article-title":"Capillarization and venularization of hepatic sinusoids in porcine serum-induced rat liver fibrosis: a mechanism to maintain liver blood flow","volume":"18","author":"Bhunchet","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib20","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/S0399-8320(05)82223-7","article-title":"Prolonged cholestasis associated with short-term use of celecoxib","volume":"29","author":"Chamouard","year":"2005","journal-title":"Gastroenterol Clin Biol"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10787-006-1506-8","article-title":"Chronic effects of celecoxib, a cyclooxygenase-2 inhibitor, cause enhanced alcohol-induced liver steatosis in rats","volume":"14","author":"Bykov","year":"2006","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s001090000094","article-title":"New insights into the role of COX 2 in inflammation","volume":"78","author":"Gilroy","year":"2000","journal-title":"J Mol Med"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib23","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1021\/tx0155505","article-title":"A protective role for cyclooxygenase-2 in drug-induced liver injury in mice","volume":"14","author":"Reilly","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/lt.500020302","article-title":"Prostaglandins in liver failure and transplantation: regeneration, immunomodulation, and cytoprotection. Prostaglandins in Liver Transplantation Research Group","volume":"2","author":"Peltekian","year":"1996","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib25","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.2174\/138161206777947678","article-title":"The role of prostaglandins in liver ischemia-reperfusion injury","volume":"12","author":"Hossain","year":"2006","journal-title":"Curr Pharm Des"},{"issue":"1","key":"10.1016\/j.prostaglandins.2008.10.002_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0163-7258(93)90067-N","article-title":"Liver cytoprotection by prostaglandins","volume":"58","author":"Quiroga","year":"1993","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.prostaglandins.2008.10.002_bib27","first-page":"1419","article-title":"Effect of misoprostol on the course of viral hepatitis B","volume":"44","author":"Flisiak","year":"1997","journal-title":"Hepatogastroenterology"}],"container-title":["Prostaglandins &amp; Other Lipid Mediators"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882308000683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098882308000683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T20:56:44Z","timestamp":1545685004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098882308000683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":27,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["S1098882308000683"],"URL":"https:\/\/doi.org\/10.1016\/j.prostaglandins.2008.10.002","relation":{},"ISSN":["1098-8823"],"issn-type":[{"value":"1098-8823","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}